Garassino, M., Mazieres, J., Reck, M., Chouaid, C., Bischoff, H., Reinmuth, N., . . . Faivre-Finn, C. (2022). Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC: The phase 2 PACIFIC-6 trial. Journal of thoracic oncology, 17(12), . https://doi.org/10.1016/j.jtho.2022.07.1148
Chicago-Zitierstil (17. Ausg.)Garassino, Marina, et al. "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial." Journal of Thoracic Oncology 17, no. 12 (2022). https://doi.org/10.1016/j.jtho.2022.07.1148.
MLA-Zitierstil (9. Ausg.)Garassino, Marina, et al. "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial." Journal of Thoracic Oncology, vol. 17, no. 12, 2022, https://doi.org/10.1016/j.jtho.2022.07.1148.